Mounjaro, a weight loss drug launched by Eli Lilly in India, could be a game-changer and has been making waves lately. Here's what you need to know. Amy Schumer has praised weight loss drug ...

The Drug Repurposing Market was USD 35.33 Bn in 2024 and is expected to expand at a CAGR of 4.9 % from 2025 to 2032, reaching USD 51.80 Bn by 2032. The U.S. FDA approved Bristol-Myers Squibb’s ...

Novo Nordisk has experienced a 50% drop due to potential tariffs and recent clinical trial results. Read why I rate NVO stock a strong buy right now.

Dilip Shanghvi is not one for flamboyant statements or headline-grabbing moves. Yet, over the decades, the soft-spoken ...

Viking Therapeutics VKTX announced that it has completed enrolling study participants in the phase II VENTURE-Oral Dosing study, which is evaluating the safety and efficacy of the oral formulation ...

AbbVie is grappling with diminishing Humira sales and is also trading at an above-average P/E. See why I rate ABBV stock as a ...

Ask a Doctor is new series of physician-authored columns offering insights and advice on common health topics. It is not a substitute for seeking medical care. Ozempic is the only medication my ...

LONDON, United Kingdom, March 27, 2025 (EZ Newswire) -- ValueTheMarkets, a trusted resource for retail investors offering financial news, in-depth analysis, and investment insights, today shared ...

Record-Breaking Revenue of HK$553.0M and Net Profit of HK$82.8M First-ever Dividend was HK$0.277 Cents Per Share ...

The market’s focus is narrow, but step outside the spotlight and you’ll find where real momentum is building LONDON, United Kingdom, March 27, 2025 (EZ Newswire) -- ValueTheMarkets, a trusted ...